Lineage Cell Therapeutics Inc (LCTX)

[pymadams]

The latest presentation on the LCTX website shows improved visual acuity for one of the OpRegen patients. https://investor.lineagecell.com/static-files/357f7a75-1dcd-455c-8824-c304c5a02f8e
(page 17).
It shows the number of letters read by the treated eye between 20-30 letters which equates to between 20/30 and 20/25. I think we haven't seen as much detail as before. This is one patient from the most recent cohort who were 20/64 and worse.

The untreated eye is showing no letters recognised, which equates to 20/200+

This is one patient. The length of data (9 months) shows it was one of the first in cohort 4.

So, there are signs that it works to some degree in some patients. I hope they present this data at AAO in October.

I'm left wondering how many years of safety data they need before they can sell something that works.